Warner Janet V, Drinkwater Michael J, Chu Gerard J, Kelly Shane, McComish Jeremy S
Pathology and Clinical Governance, Australian Red Cross Lifeblood, Brisbane, Queensland, Australia.
School of Mathematics and Physics, University of Queensland, Brisbane, Queensland, Australia.
Vox Sang. 2025 Apr;120(4):374-382. doi: 10.1111/vox.13800. Epub 2025 Jan 29.
Serum immunoglobulin G (IgG) and total protein are used to monitor plasmapheresis donor safety. However, there is a lack of information from large donor cohorts to determine the best use of these measurements.
We identified 230,144 plasmapheresis donors making their first donation between 1 July 2020 and 31 March 2024. IgG and total protein were measured prior to the first donation and then annually, following our donor safety monitoring protocol. We considered individuals who had not donated for 12 months to estimate intra-individual biological variability of IgG. We compared four models to predict which donors would develop IgG < 6 g/L.
The IgG reference interval for the cohort was 7.67-15.6 g/L. IgG declines 5%-11% after the age of 45 years. The intra-individual biological variability of IgG (5.2%) is small, indicating that there is homeostatic set point for individual IgG. IgG is reduced by plasmapheresis but recovers to recruitment level after 12 weeks. When plasma is donated every 2-3 weeks, mean IgG plateaus 1 g/L below recruitment concentration. IgG at recruitment is the best predictor of which donors will have IgG < 6 g/L after a year of donations. Total protein is a low-value test in this context.
Plasmapheresis is safe and sustainable for almost every donor, at the 2-weekly frequency allowed in Australia. The donors most likely to experience unacceptably low IgG are those with very low recruitment IgG levels. These donors could be recommended 12-week intervals between donations or other donation types.
血清免疫球蛋白G(IgG)和总蛋白用于监测单采血浆献血者的安全性。然而,缺乏来自大量献血者队列的信息来确定这些检测指标的最佳用途。
我们确定了230144名单采血浆献血者,他们在2020年7月1日至2024年3月31日期间首次献血。按照我们的献血者安全监测方案,在首次献血前以及之后每年测量IgG和总蛋白。我们考虑那些有12个月未献血的个体,以估计IgG的个体内生物学变异性。我们比较了四种模型,以预测哪些献血者的IgG会降至<6g/L。
该队列的IgG参考区间为7.67 - 15.6g/L。45岁以后,IgG下降5% - 11%。IgG的个体内生物学变异性较小(5.2%),表明个体IgG存在稳态设定点。单采血浆会使IgG降低,但12周后会恢复到采血时的水平。当每2 - 3周采集一次血浆时,平均IgG稳定在比采血浓度低1g/L的水平。采血时的IgG是预测哪些献血者在献血一年后IgG会<6g/L的最佳指标。在此背景下,总蛋白检测价值较低。
在澳大利亚允许的两周一次的频率下,单采血浆对几乎所有献血者来说都是安全且可持续的。最有可能出现不可接受的低IgG水平的献血者是那些采血时IgG水平非常低的人。对于这些献血者,可以建议延长至12周的献血间隔或采用其他献血类型。